Axogen, Inc. Common Stock vs. CONMED Corporation
CONMED Corporation (CNMD) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| AXGN | CNMD | |
|---|---|---|
| Market Cap | $2.27 billion | $1.38 billion |
| Revenue (TTM) | $251.17 million | $1.37 billion |
| Net Income (TTM) | $-33,548,000 | $56.50 million |
CNMD leads on 2 of 3 size & scale factors.
Valuation
| AXGN | CNMD | |
|---|---|---|
| P/E Ratio | — | 24.94 |
| Price / Book | 8.84 | 1.33 |
| Price / Sales | 9.02 | 1.01 |
CNMD leads on 2 of 2 valuation factors.
Profitability
| AXGN | CNMD | |
|---|---|---|
| Net Margin | -13.36% | 4.12% |
| Return on Equity | -13.09% | 5.43% |
CNMD leads on 2 of 2 profitability factors.
Dividend
| AXGN | CNMD | |
|---|---|---|
| Dividend Yield | — | 1.73% |
| Payout Ratio | — | 43.24 |
AXGN and CNMD split the dividend factors evenly.
Risk & Sentiment
| AXGN | CNMD | |
|---|---|---|
| Short Interest | 2.05% | 2.50% |
AXGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: AXGN overview, AXGN financials, CNMD overview, CNMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
